LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
BT-20 AZD7762
0.37
uM
LJP6
 72
hr
 1657 4158 5383 0.7729 0.7188
BT-20 AZD7762
0.12
uM
LJP6
 72
hr
 1657 5352 5383 0.9954 0.9950
BT-20 AZD7762
0.04
uM
LJP6
 72
hr
 1657 5881 5383 1.0932 1.1076
BT-20 AT-7519
10
uM
LJP6
 72
hr
 1657 922 5383 0.1714 -0.2941
BT-20 AT-7519
3.33
uM
LJP6
 72
hr
 1657 1217 5383 0.2261 -0.1671
BT-20 AT-7519
1.11
uM
LJP6
 72
hr
 1657 1474 5383 0.2737 -0.0680
BT-20 AT-7519
0.37
uM
LJP6
 72
hr
 1657 1889 5383 0.3511 0.0799
BT-20 AT-7519
0.12
uM
LJP6
 72
hr
 1657 4313 5383 0.8018 0.7564
BT-20 AT-7519
0.04
uM
LJP6
 72
hr
 1657 5115 5383 0.9511 0.9422
BT-20 Seliciclib
10
uM
LJP5
 72
hr
 1657 2184 5588 0.3907 0.1692
BT-20 Seliciclib
3.33
uM
LJP5
 72
hr
 1657 4547 5588 0.8139 0.7783
BT-20 Seliciclib
1.11
uM
LJP5
 72
hr
 1657 4763 5588 0.8525 0.8258
BT-20 Seliciclib
0.37
uM
LJP5
 72
hr
 1657 5212 5588 0.9328 0.9221
BT-20 Seliciclib
0.12
uM
LJP5
 72
hr
 1657 5585 5588 0.9996 0.9994
BT-20 Seliciclib
0.04
uM
LJP5
 72
hr
 1657 5718 5588 1.0234 1.0266